Carbohydrates metallography all imp clinical values
Reading File
Finding Sources
Finding Sources
Searching PubMed
"carbohydrate metabolism" AND clinical
Searching the Web
clinical laboratory glucose reference ranges fasting oral glucose tolerance test HbA1c ADA diagnosis
Reading File
Reading File
Reading Web Page
https://diabetes.org/about-diabetes/diagnosis
Carbohydrate metabolism: important clinical values and correlations
1. Core blood glucose values
| Test / condition | Value |
|---|---|
| Normal fasting plasma glucose (FPG) | 70-99 mg/dL (3.9-5.5 mmol/L) |
| Impaired fasting glucose / prediabetes | 100-125 mg/dL (5.6-6.9 mmol/L) |
| Diabetes mellitus, fasting | ≥126 mg/dL (≥7.0 mmol/L) |
| Normal 2-hour 75 g OGTT | <140 mg/dL (<7.8 mmol/L) |
| Impaired glucose tolerance | 140-199 mg/dL (7.8-11.0 mmol/L) |
| Diabetes, 2-hour OGTT | ≥200 mg/dL (≥11.1 mmol/L) |
| Random plasma glucose diagnostic of diabetes | ≥200 mg/dL with classic symptoms |
| Hypoglycemia alert value | <70 mg/dL (<3.9 mmol/L) |
| Clinically significant hypoglycemia | <54 mg/dL (<3.0 mmol/L) |
| Severe hypoglycemia | No fixed glucose value. Requires assistance from another person. |
A fasting serum glucose reference interval in laboratory texts is commonly 70-100 mg/dL; hypoglycemia should prompt concern, especially at very low values. Henry's Clinical Diagnosis and Management by Laboratory Methods, p. 139. Current diabetes thresholds are summarized by the American Diabetes Association.
2. HbA1c values
HbA1c reflects mean glycemia over approximately the prior 2-3 months, because glucose nonenzymatically glycates hemoglobin.
| HbA1c | Interpretation |
|---|---|
| <5.7% | Normal |
| 5.7-6.4% | Prediabetes |
| ≥6.5% | Diabetes mellitus |
| Usual treatment target for many nonpregnant adults with diabetes | <7%, individualized |
Approximate HbA1c to estimated average glucose (eAG):
| HbA1c | eAG |
|---|---|
| 6% | 126 mg/dL |
| 6.5% | 140 mg/dL |
| 7% | 154 mg/dL |
| 8% | 183 mg/dL |
| 9% | 212 mg/dL |
| 10% | 240 mg/dL |
Important limitations of HbA1c: unreliable or needs cautious interpretation in hemolytic anemia, acute blood loss/transfusion, hemoglobin variants, severe kidney disease, pregnancy, and conditions changing red-cell lifespan. See the ADA's A1c interpretation guide.
3. Important carbohydrate-related tests
| Test | Normal / important value | Clinical significance |
|---|---|---|
| Urine glucose | Normally negative | Appears when plasma glucose exceeds renal threshold, often about 180 mg/dL. Seen in diabetes or renal glycosuria. |
| Urine ketones | Negative | Positive in diabetic ketoacidosis (DKA), starvation, vomiting, alcoholism. |
| Blood beta-hydroxybutyrate | Usually <0.6 mmol/L | ≥3.0 mmol/L with acidosis strongly supports DKA. |
| Serum lactate | Usually about 0.5-2.0 mmol/L | Elevated in tissue hypoxia/shock, sepsis, seizures, severe liver disease, some drugs, mitochondrial disorders. |
| Anion gap | About 8-12 mEq/L without K | Raised in DKA and lactic acidosis. |
| C-peptide | Lab-dependent | Reflects endogenous insulin secretion. Low in type 1 diabetes or exogenous insulin use; preserved/high in insulin resistance or insulinoma. |
| Insulin level | Lab-dependent | Interpret only along with glucose and C-peptide. |
4. Major pathways and their clinical relevance
A. Glycolysis
Glucose → pyruvate/lactate, producing ATP.
- Occurs in all cells and is the only ATP source for cells without mitochondria, such as red blood cells.
- Anaerobic glycolysis produces lactate.
- Pyruvate kinase deficiency causes chronic hemolytic anemia due to low RBC ATP.
- Phosphofructokinase deficiency (Tarui disease, GSD VII) causes exercise intolerance, cramps, and hemolysis.
- High lactate indicates increased anaerobic metabolism or impaired clearance.
B. Pyruvate dehydrogenase reaction
Pyruvate → acetyl-CoA
- Requires thiamine (B1), lipoic acid, FAD, NAD+, CoA.
- Deficiency causes pyruvate diversion to lactate, resulting in lactic acidosis, neurologic dysfunction, and developmental delay.
- Thiamine deficiency can impair carbohydrate oxidation and contribute to lactic acidosis.
C. TCA cycle
Acetyl-CoA oxidation produces NADH/FADH2 for oxidative phosphorylation.
- Requires mitochondrial function and adequate oxygen.
- Impaired oxidative metabolism can raise lactate.
- Arsenic inhibits lipoic acid-dependent enzymes, including pyruvate dehydrogenase.
D. Glycogenesis
Glucose → glycogen, mainly in liver and skeletal muscle.
- Stimulated by insulin.
- Liver glycogen maintains blood glucose between meals.
- The liver has a “glucose buffer” function: it stores excess glucose after meals and releases glucose when blood glucose falls. Guyton and Hall Textbook of Medical Physiology, carbohydrate metabolism section.
E. Glycogenolysis
Glycogen → glucose.
- Stimulated by glucagon in liver and epinephrine in liver and muscle.
- Muscle lacks glucose-6-phosphatase, so muscle glycogen cannot directly raise blood glucose.
Important glycogen storage diseases
| Disorder | Enzyme defect | Key findings |
|---|---|---|
| Von Gierke disease, GSD I | Glucose-6-phosphatase | Severe fasting hypoglycemia, hepatomegaly, lactic acidosis, hyperuricemia, hypertriglyceridemia |
| Pompe disease, GSD II | Lysosomal acid alpha-glucosidase | Cardiomyopathy, hypotonia, macroglossia |
| Cori disease, GSD III | Debranching enzyme | Hepatomegaly, hypoglycemia, muscle involvement |
| Andersen disease, GSD IV | Branching enzyme | Cirrhosis, hepatosplenomegaly, liver failure |
| McArdle disease, GSD V | Muscle glycogen phosphorylase | Exercise intolerance, cramps, myoglobinuria, no rise in lactate after exercise |
| Hers disease, GSD VI | Liver glycogen phosphorylase | Mild fasting hypoglycemia, hepatomegaly |
F. Gluconeogenesis
Lactate, glycerol, and glucogenic amino acids → glucose.
- Occurs mainly in the liver, and also kidney during prolonged fasting.
- Stimulated by glucagon, cortisol, epinephrine, and fasting.
- Defects or severe hepatic failure can cause fasting hypoglycemia and lactic acidosis.
- Alcohol increases NADH, inhibiting gluconeogenesis and predisposing to hypoglycemia and lactic acidosis, especially in fasting individuals.
G. Pentose phosphate pathway, HMP shunt
Produces NADPH and ribose-5-phosphate.
- NADPH keeps glutathione reduced, protecting RBCs from oxidative injury.
- G6PD deficiency causes episodic hemolytic anemia after oxidant stress, including infection, fava beans, and oxidant drugs.
- Findings: jaundice, elevated indirect bilirubin and LDH, low haptoglobin, bite cells, Heinz bodies.
H. Fructose metabolism
| Disorder | Defect | Findings |
|---|---|---|
| Essential fructosuria | Fructokinase deficiency | Benign, fructose in urine |
| Hereditary fructose intolerance | Aldolase B deficiency | Vomiting, hypoglycemia, jaundice, liver dysfunction after fructose/sucrose intake; avoid fructose, sucrose, sorbitol |
I. Galactose metabolism
| Disorder | Defect | Findings |
|---|---|---|
| Classic galactosemia | Galactose-1-phosphate uridyltransferase deficiency | Jaundice, hepatomegaly, vomiting, cataracts, failure to thrive, E. coli sepsis in neonates |
| Galactokinase deficiency | Galactokinase | Infantile cataracts, usually no severe liver disease |
5. Hormonal regulation
| Hormone | Major effect on carbohydrate metabolism |
|---|---|
| Insulin | Lowers blood glucose: increases glucose uptake in muscle/adipose, glycolysis, glycogenesis, lipogenesis; decreases gluconeogenesis and lipolysis |
| Glucagon | Raises blood glucose: increases hepatic glycogenolysis and gluconeogenesis |
| Epinephrine | Raises glucose during stress/exercise; increases glycogenolysis and lipolysis |
| Cortisol | Raises glucose by increasing gluconeogenesis and insulin resistance |
| Growth hormone | Reduces peripheral glucose uptake and raises blood glucose |
6. High-yield clinical patterns
Diabetes mellitus
- Persistent hyperglycemia due to insufficient insulin secretion, insulin action, or both.
- Chronic hyperglycemia causes microvascular complications: retinopathy, nephropathy, neuropathy.
- It also increases macrovascular disease risk.
Diabetic ketoacidosis
Typical biochemical pattern:
- Hyperglycemia, often >250 mg/dL
- High anion gap metabolic acidosis
- Positive ketones, especially raised beta-hydroxybutyrate
- Low bicarbonate and low pH
- Total body potassium depletion may exist even when serum potassium is normal or raised.
Hyperosmolar hyperglycemic state
- Marked hyperglycemia, often >600 mg/dL
- High serum osmolality, severe dehydration
- Minimal ketosis/acidosis compared with DKA.
Hypoglycemia
Symptoms include sweating, tremor, palpitations, hunger, confusion, seizure, or coma.
Common causes:
- Insulin or sulfonylurea excess
- Fasting/alcohol use
- Insulinoma
- Adrenal insufficiency
- Severe liver disease
- Sepsis
- Inborn metabolic disorders in children
Liver disease
The liver stores glycogen, converts fructose and galactose to glucose, and performs gluconeogenesis. Liver dysfunction therefore predisposes to unstable glycemia, including exaggerated post-meal hyperglycemia and fasting hypoglycemia. Guyton and Hall Textbook of Medical Physiology, carbohydrate metabolism section.
One-line exam summary
Carbohydrate metabolism maintains blood glucose through glycolysis, glycogenesis, glycogenolysis, gluconeogenesis, the TCA cycle, and the HMP shunt; its major clinical disorders are diabetes, hypoglycemia, lactic acidosis, glycogen storage diseases, G6PD deficiency, galactosemia, and hereditary fructose intolerance.
This is a shared conversation. Sign in to Orris to start your own chat.